Android Apple

Quest Diagnostics Incorporated's (NYSE:DGX) Intrinsic Value Is Potentially 95% Above Its Share Price

By Yahoo! Finance   |   4 months ago
Quest Diagnostics Incorporated's (NYSE:DGX) Intrinsic Value Is Potentially 95% Above Its Share Price

An analyst price target for DGX is US$151, 45% below the fair value estimate. A Discounted Cash Flow model is used to evaluate Quest Diagnostics as an investment opportunity, projecting future cash flows and discounting them.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.